Martin Schmieg

Advanced Bionics Corp. develops, manufactures, and markets bionic technologies for neurological conditions. Its neuromodulation technology includes neurostimulators, programmable drug pumps, and cochlear implants. The company was founded by Alfred Mann in 1993 and is headquartered in Sylmar, CA.

Isolagen Technologies, Inc. researches and develops cellular technology. specializes in the development and commercialization of autologous cellular system. The company is headquartered in Houston, TX.

Soar Ventures provides advisory services and venture funding to entrepreneurs. The private company is based in Delray Beach. The American company was founded by Martin E. Schmieg. Martin E. Schmieg has been the CEO since incorporation.

Sapientia Pharmaceuticals, Inc. distributes pharmaceutical products. It develops novel targeted therapeutics for multiple indications including several cancers and fibrotic diseases. The company was founded by Douglas V. Faller and Robert M. Williams and is headquartered in Havertown, PA.

ClearIt LLC engages in tattoo removals. It is to design, develop and market the first effective, painless, single treatment tattoo ERASER™ System. The company was founded by Dr. James W. Winkelman and Martin E. Schmieg in 2013 and is headquartered in Boston, MA.

DIgSILENT Holding GmbH provides professional, scientific, and technical services. The private company is based in Tubingen, Germany. The CEO of the German company is Martin E. Schmieg.

Clear Intradermal Technologies, Inc. has invented the Eraser™ system, which is an efficient, pain-free, and effective device that promises to transform the patient journey. The company is based in New York, NY. The company's team of proven, passionate innovators is committed to delivering their patented removal system to affordably, comfortably, and time-efficiently "clear" unwanted tattoos. The company was founded in 2003 by James W. Winkelman, Martin E. Schmieg. The CEO is Gordon E. Nye.

Boutique Venture Partners LLC (Boutique Venture Partners) is a venture capital firm founded in 2020 by S. Thaddeus Connelly and Rami El Assal. The firm is headquartered in Palo Alto, California.

BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada.